Free Trial

Advisory Services Network LLC Raises Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Axon Enterprise logo with Aerospace background

Advisory Services Network LLC lifted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 60.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,497 shares of the biotechnology company's stock after purchasing an additional 944 shares during the quarter. Advisory Services Network LLC's holdings in Axon Enterprise were worth $1,484,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in shares of Axon Enterprise by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Axon Enterprise by 3.7% during the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock valued at $1,095,542,000 after acquiring an additional 65,097 shares in the last quarter. Alliancebernstein L.P. raised its holdings in Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after acquiring an additional 812,337 shares during the last quarter. Norges Bank purchased a new stake in Axon Enterprise during the 4th quarter valued at $482,081,000. Finally, GQG Partners LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth $478,349,000. Institutional investors own 79.08% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently commented on AXON. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective for the company. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Barclays reissued a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $626.45.

Read Our Latest Research Report on AXON

Axon Enterprise Price Performance

Shares of AXON stock traded down $12.32 on Friday, hitting $559.53. 519,604 shares of the stock traded hands, compared to its average volume of 796,658. The firm has a market cap of $42.87 billion, a price-to-earnings ratio of 144.58, a PEG ratio of 5.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a 50 day simple moving average of $558.46 and a two-hundred day simple moving average of $564.23. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99.

Insider Activity

In related news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 6.10% of the company's stock.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines